A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 825-837

  Naghibi, M ^a,b   Smith, T R ^a   Elia, M ^a,b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cost effectiveness; ICER; Malignancy; Nutrition; Palliative; Parenteral

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM CANCER; EVIDENCE BASED PRACTICE; FEMALE GENITAL TRACT CANCER; HEAD AND NECK CANCER; HEALTH CARE COST; HOME CARE; HOSPITAL ADMISSION; HUMAN; INOPERABLE CANCER; INTESTINE OBSTRUCTION; LUNG CANCER; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PROGRAM COST EFFECTIVENESS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SURVIVAL RATE; SYSTEMATIC REVIEW; UROGENITAL TRACT CANCER; VALIDATION STUDY; COST BENEFIT ANALYSIS; FACTUAL DATABASE; INFLAMMATORY BOWEL DISEASES; REPRODUCIBILITY; SURVIVAL ANALYSIS;

COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; HUMANS; INFLAMMATORY BOWEL DISEASES; PARENTERAL NUTRITION, HOME; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 84939270514     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.09.010     Document Type: Article

References (47)

1. King L.A., Carson L.F., Konstantinides N., House M.S., Adcock L.L., Prem K.A., et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecol Oncol 1993, 51:377-382.
2. Bozzetti F., Santarpia L., Pironi L., Thul P., Klek S., Gavazzi C., et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 2014, 25:487-493.
3. Howard L., Ament M., Fleming C.R., Shike M., Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the united states. Gastroenterology 1995, 109:355-365.
4. Cozzaglio L., Balzola F., Cosentino F., DeCicco M., Fellagara P., Gaggiotti G., et al. Outcome of cancer patients receiving home parenteral nutrition. Italian society of parenteral and enteral nutrition (S.I.N.P.E. J Parenter Enter Nutr 1997, 21:339-342.
5. Wanden Berghe C., Gómez Candela C., Chicharro L., Cuerda C., Martínez Faedo C., Virgili N., et al. Home parenteral nutrition registry in spain for the year 2010: Nadya-senpe group [spanish]. Nutr Hosp 2011, 26:1277-1282.
6. Smith T.R.M.A., Hirst A., Stratton R., Baxter J. Annual bans report, 2011 2011, British Artificial Nutrition Survey.
7. Baxter J.P., McKee R.F. The Scottish home parenteral nutrition managed clinical network: one year on. Clin Nutr 2003, 22:501-504.
8. Soo I., Gramlich L. Use of parenteral nutrition in patients with advanced cancer. Appl Physiology Nutr Metabolism-Physiologie Appliquee Nutr Metabolisme 2008, 33:102-106.
9. Gillanders L.A., Angstmann K., Thomson Ball P., O'Callaghan A., Wong T. Auspen hpn register 2011. Aust Soc Parenter Enter Nutr 2011.
10. Bozzetti F., Arends J., Lundholm K., Micklewright A., Zurcher G., Muscaritoli M. Espen guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 2009, 28:445-454.
11. August D.A., Huhmann M.B. A.S.P.E.N. Clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enter Nutr 2009, 33:472-500.
12. Bachmann P., Marti-Massoud C., Blanc-Vincent M.P., Desport J.C., Colomb V., Dieu L., et al. Summary version of the standards, options and recommendations for palliative or terminal nutrition in adults with progressive cancer. Electron J Oncol 2001, 2003:67-71.
13. Muscaritoli M., Molfino A., Laviano A., Rasio D., Fanelli F.R. Parenteral nutrition in advanced cancer patients. Crit Rev Oncol Hematol 2012, 84:26-36.
14. Shang E., Weiss C., Post S., Kaehler G. The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer. [Retraction in j parenter enteral nutr. 2012 jul;36(4):485; pmid: 22715106]. J Parenter Enter Nutr 2006, 30:222-230.
15. Hasenberg T., Essenbreis M., Herold A., Post S., Shang E. Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective, randomized clinical trial. Colorectal Dis 2010, 12:E190-E199.
16. Richards D.M., Irving M.H. Cost-utility analysis of home parenteral nutrition. Br J Surg 1996, 83:1226-1229.
17. Detsky A.S., McLaughlin J.R., Abrams H.B., Whittaker J.S., Whitwell J., L'Abbe K., et al. A cost-utility analysis of the home parenteral nutrition program at toronto general hospital: 1970-1982. J Parenter Enter Nutr 1986, 10:49-57.
18. Vafa H., Ballarin A., Arvanitakis M., Vereecken S., Dutat F., Lagasse C., et al. Lessons from a 20 year experience of home parenteral nutrition in adult patients. Acta Gastro-Enterologica Belg 2010, 73:451-456.
19. Jirka A., Svanda J., Tesinsky P., Smejkalova V. National registry of home parenteral and enteral nutrition in czech republic: the 2010 data. Clin Nutr Suppl 2011, 6(1):87.
20. Takagi Y., Okada A., Sato T., Fukushima T., Shirotani N., Osawa Y., et al. Report on the first annual survey of home parenteral nutrition in Japan. Surg Today 1995, 25:193-201.
21. Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. Cochrane Bias Methods G, Cochrane Statistical Methods G.
22. Moher D., Altman D.G., Liberati A., Tetzlaff J. Prisma statement. Epidemiology 2011, 22:128. author reply.
23. Shils M.E., Wright W.L., Turnbull A., Brescia F. Long-term parenteral nutrition through an external arteriovenous shunt. N Engl J Med 1970, 283:341-344.
24. Milne R., Donald A., Chambers L. Piloting short workshops on the critical appraisal of reviews. Health Trends 1995, 27:120-123.
25. August D.A., Thorn D., Fisher R.L., Welchek C.M. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. J Parenter Enter Nutr 1991, 15:323-327.
26. Mercadante S. Parenteral nutrition at home in advanced cancer patients. J Pain & Symptom Manag 1995, 10:476-480.
27. Duerksen D.R., Ting E., Thomson P., McCurdy K., Linscer J., Larsen-Celhar S., et al. Is there a role for tpn in terminally ill patients with bowel obstruction?. Nutrition 2004, 20:760-763.
28. Pasanisi F., Orban A., Scalfi L., Alfonsi L., Santarpia L., Zurlo E., et al. Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 2001, 17:581-584.
29. Bozzetti F., Cozzaglio L., Biganzoli E., Chiavenna G., De Cicco M., Donati D., et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002, 21:281-288.
30. Brard L., Weitzen S., Strubel-Lagan S.L., Swamy N., Gordinier M.E., Moore R.G., et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol 2006, 103:176-180.
31. Chermesh I., Mashiach T., Amit A., Haim N., Papier I., Efergan R., et al. Home parenteral nutrition for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Med Oncol 2011, 28:83-88.
32. Pironi L., Ruggeri E., Tanneberger S., Giordani S., Pannuti F., Miglioli M. Home artificial nutrition in advanced cancer. J R Soc Med 1997, 90:597-603.
33. National Office of Statistics Prices, indices and inflation Available from:. http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Price+Indices+and+Inflation.
34. Curtis L. Unit costs of health and social care 2013 2013, Personal Social Services Research Unit, University of Kent.
35. Park S.M., Park M.H., Won J.H., Lee K.O., Choe W.S., Heo D.S., et al. EuroQol and survival prediction in terminal cancer patients: a multi-center prospective study in hospice-palliative care units. Support Care Cancer 2006, 14:329-333.
36. Farkkila N., Torvinen S., Roine R.P., Sintonen H., Hanninen J., Taari K., et al. Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Qual Life Res 2014, 23:1387-1394.
37. Mercadante S. Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 1995, 3:190-193.
38. AbuRustum N.R., Barakat R.R., Venkatraman E., Spriggs D. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol 1997, 64:493-495.
39. Fan B.G. Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. J Parenter Enter Nutr 2007, 31:508-510.
40. Bossola M., Pacelli F., Rosa F., Tortorelli A., Battista Doglietto G.B.G. Does nutrition support stimulate tumour growth in humans?. Nutr Clin Pract Nutr Clin Pract 2011, 26:174-180.
41. Orrevall Y., Tishelman C., Herrington M.K., Permert J. The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 2004, 23:1280-1287.
42. Orrevall Y., Tishelman C., Permert J. Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr Clin Nutr 2005, 24:961-970.
43. Claxton K.S., Soares M., Rice N., Spackman E., Hinde S., Smith P.C., et al. Written evidence to NICE, 61 2012, Available from:. http://www.publications.parliament.uk/pa/cm201213/cmselect/cmhealth/782/782vw55.htm.
44. Wyers C.E., Reijven P.L., Evers S.M., Willems P.C., Heyligers I.C., Verburg A.D., et al. Cost-effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporos Int 2013, 24:151-162.
45. Cookson R. Willingness to pay methods in health care: a sceptical view. Health Econ 2003, 12:891-894.
46. Mason H., Jones-Lee M., Donaldson C. Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ 2009, 18:933-950.
47. Kind P., Dolan P., Gudex C., Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316(7133):736-741.